PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
iHealthcareAnalyst, Inc.

Press Release


Receive press releases from iHealthcareAnalyst, Inc.: By Email RSS Feeds:

iHealthcareAnalyst, Inc. Reports Life Threatening Neisseria Meningitides Infections to Drive Meningococcal Vaccines Market to USD 3.8 Billion by 2020


Meningococcal Vaccines Market Global Vaccine Products Analysis and Forecast 2013-2020

Maryland Heights, MO, July 27, 2016 --(PR.com)-- The global meningococcal vaccines market is estimated to reach USD 3.8 Billion in 2020, growing at a CAGR of 12.6% from 2016 to 2020, according to a new market research report Meningococcal Vaccines Market – Global Vaccine Products Analysis and Forecast 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Meningococcal Vaccines Market – Global Vaccine Products Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/meningococcal-vaccines-market/

Meningococcal vaccines are now available that help protect against all three serogroups of meningococcal disease that are most commonly observed (serogroups B, C and Y), but they will not prevent all cases. There are three kinds of meningococcal vaccines available: Meningococcal combination vaccines (Bexsero, Trumenba, MenHibrix, Menitorix); Meningococcal conjugate vaccines (Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT); Meningococcal polysaccharide vaccine (Bi Meningo, Mencevax, Menomune, NmVac4, Quadri Meningo). The global meningococcal vaccines market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market and also forecasts growth trends (CAGR% - 2016 to 2020). It also covers the major companies operating in the market and provides detailed market analysis of the different vaccine types available in the global market.

The global meningococcal vaccines market is segmented as:
1. Vaccine Type
1.1. Combination Vaccines
1.1.1.Bexsero
1.1.2. MenHibrix
1.1.3. Menitorix
1.1.4. Trumenba
1.2. Conjugate Vaccines
1.2.1. Menactra
1.2.2. MenAfriVac
1.2.3. Meningitec
1.2.4. Menjugate
1.2.5. Menveo
1.2.6. NeisVac-C
1.2.7. Nimenrix
1.2.8. NmVac4-DT
1.3. Polysaccharide Vaccines
1.3.1. Bi Meningo
1.3.2. Mencevax
1.3.3. Menomune
1.3.4. NmVac4
1.3.5. Quadri Meningo

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Baxter International, Inc.
3.2. Biomed Pvt., Ltd.
3.3. GlaxoSmithKline plc
3.4. JN-International Medical Corporation
3.5. Nuron Biotech, Inc.
3.6. Pfizer, Inc.
3.7. Sanofi SA
3.8. Serum Institute of India, Ltd.

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com

Website: http://www.ihealthcareanalyst.com
Contact Information
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
Contact
http://www.ihealthcareanalyst.com/

Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.
Promote Your Business